K. K. Divine

Predicting lung cancer by detecting aberrant promoter methylation in sputum.

J. Herman, S. Baylin, F. Gilliland, 2000, Cancer research.

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

F. Gilliland, R. Crowell, S. Belinsky, 2002, Cancer research.

Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers

F. Gilliland, S. Belinsky, K. Divine, 2005, International journal of cancer.

Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

F. Gilliland, S. Belinsky, K. Divine, 2003, Cancer research.

Conditioned saccharin aversions in rats as a result of cutaneous nicotine or intraperitoneal nicotine administered in divided doses

Gene A. Moore, K. Divine, F. Etscorn, 1987, Pharmacology Biochemistry and Behavior.

The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung.

F. Gilliland, R. Crowell, S. Belinsky, 2001, Mutation research.

Promoter Hypermethylation of the O 6-Methylguanine-DNA Methyltransferase Gene : More Common in Lung Adenocarcinomas from Never-Smokers than Smokers and Associated with Tumor Progression 1

F. Gilliland, S. Belinsky, K. Divine, 2003 .

Trigeminal uptake and clearance of inhaled manganese chloride in rats and mice.

W. Staines, K. Divine, J. Lewis, 2003, Neurotoxicology.